2Shilling HG, Guethlein LA, Cheng NW, et al. Allelic polymorphism synergizes with variable gene content to individualize hu-man KIR genotype [ J ]. J lmmuno1,2002,169 ( 9 ) : 5118-5129
3Hsu KC, Liu XR, Selvakumar A, et al . Killer Ig-like receptor haplotype analysis by gene content : evidence for genomic diversity with a minimum of six basic framework haplotypes,each with multiple subsets[J]. J Immunol, 2002,169(9) :5118-5129
4Farag SS, Fehniger TA, Ruggeri L, et al. Natural Killer cell receptors new biology and insight into the graft-versus-leukemia effect [ J ]. Blood,2002,100 (6) : 1935-1947
5Lopez-Botet M, Bellon T, Llano M, et al. Paired inhibitory and triggering NK cell receptors for HLA class I molecules [ J ]. Hum Immuno1,2000,61 ( 1 ) :7-17
6Boyington JC, Motyka SA, Schuck P, et al. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I M HC ligand [ J ]. Nature, 2000,405 ( 6786 ) : 537-543
7Rajagopalan S, Fu J, Long EO. Cutting edge: induction of IFN- gamma production but not cytotoxicity by the killer cell Ig-like receptor KIR2DIA (CD158d) in resting NK cells[J]. J Immunol. 2001,15;167(4) :1877-1881
8Williams F, Meenagh A, Sleator C, et al. Investigation of killer cell immunoglobulinlike receptor gene diversity: I. KIR2DL4 [J]. Hum Immunol,2004,65( 1 ) :31-38
9Frassati C ,Touinssi M ,Heard C ,et al. Geographic distribution of the two allelic forms of KIR2DS4. Interest in anthropological studies [ J ]. Tissue Antigens. 2006,67 ( 5 ) : 356-367
2Hsu KC,Keever-Talor CA,Wilton A,et al.Improved outcome in HLA-identical sibling hematopoietic stem-cell transplantation for acute myelogenous leukemia predicted by KIR and HLA genotypes.Blood,2005,105:4878-4884.
3Cook MA,Milligan DW,Fegan CD,et al.The impact of donor KIR and patient HLA-C genotypes on outcome following HLA-identical sibling hematopoietic stem cell transplantation for myeloid leukemia.Blood,2004,103:1521-1526.
4Shilling HG,McQueen KL,Cheng NW,et al.Reconstitution of NK cell receptor repertoire following HLA-matched hematopoietic cell transplantation.Blood,2003,101:3730-3740.
5Shlomchik WD,Couzens MS,Tang CB,et al,Prevention of graft versus host disease by inactivation of host antigen-presenting cells.Science,1999,285:412-415.
6Schaffer M,Malmberg KJ,Ringden O,et al.Increased infectionrelated mortality in KIR ligand-mismatched unrelated allogeneic hematopoietic stem-cell transplantation.Transplantation,2004,78:1081-1085.
7Boyington JC,Motyka SA,Schuck P,et al.Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class ⅠMHC ligand.Nature,2000,405:537-543.
8Boyington JC,Brooks AG,Sun PD.Structure of killer cell immunoglobulin-like receptors and their recognition of class Ⅰ MHC molecules.Immunol Rev,2001,181:66-78.
9Biassoni R,Cantoni C,Falco M,et al.The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions.J Exp Med,1996,183:645-650.
3Kalkunte S, Chichester CO, Gotsch F, et al. Evolution of non - cyto-toxic uterine natural killer cells[ J ]. Am J Reprod Immunol,2008,59(5):425-432.
4LiHua Hou, Bo Jiang, Minghua Chen, et al. The characteristics ofallelic polymorphim in killer immunoglobulin - like receptor frame-work genes in African Americans [ J ]. Immunogenetics, 2011 Sep-tember, 63 (9) : 549-559.
5Nowak I,Majorczyk E, Ploski R, et al. Lack of KIR2DL gene in afertile Caucasian woman. [ J ]. Tissue Antigens, 2011 Aug, 78(2):115 -9.
6FloresAC,Marcos CY,Paladino N, et al. KIR recep tors andHLA2Cin the maintenance of pregnancy [J ] . Tissue Antigens, 2007, 69 ( 1 ):1122-1131.
7Shirer JA Jr, Ray MC. Familial occurrence of lichen Sclerosus et alrophicus case reports of a mother and daughter [ J ]Arch Dermatol, 1987,123 (4) :485-488.
8Kaufman RH, Gardner HL, Brown D Jr, et al. Vulvar dystrophia an evaluation[J]. Am J Obstet Gynecol, 1974,120(3) :363-367.
9Gao XH, Bamardo MC, Winsey S, et al. The association between HLA DR, DQ antigens, and vulval lichen sc|erosus in the UK: HLA DRBll2 and its associated DRBll2/DQB10301/04/09/010 haplotype confers susceptibility to vulval lichen sclerosus, and HLA DRB10301/04 and its associated DRB10301/04/DQB10201/02/03 haplotype protects from vulval lichen sclerosus [ J ]. J Invest Dermatol, 2005,125 (5) :895-899.
10Yesudian P D, Sugunendran H, Bates CM, et al. Lichen sclero- sus[J]. Int J STD AIDS, 2005,16(7) :465-473.
